Abstract
New technologies have made it possible to demonstrate the existence of ocular biomarkers of many of the neurodegenerative diseases, contributing to their diagnosis, classification and even to the control of responses to treatments. This SIS aims to update some of the ocular findings of diseases such as Multiple Sclerosis, Alzheimer's, or Amyotrophic Lateral Sclerosis.Essential aspects of techniques such as OCT and eye‐tracker will be addressed. Emphasis will be placed on the standardization of OCT for a correct application in neuro‐ophthalmology and on the possible uses of eye‐tracker systems to give information on alterations in eye movement control systems.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
